Qube Research & Technologies LTD Isoray, Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Isoray, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 246,244 shares of ISR stock, worth $169,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
246,244Holding current value
$169,908% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ISR
# of Institutions
102Shares Held
248MCall Options Held
0Put Options Held
0-
Deerfield Management Company, L.P. (Series C) New York, NY28.2MShares$19.4 Million0.4% of portfolio
-
Commodore Capital LP New York, NY21.1MShares$14.5 Million1.25% of portfolio
-
Marshall Wace, LLP London, X019MShares$13.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.8MShares$12.3 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY14.7MShares$10.2 Million1.59% of portfolio
About Isoray, Inc.
- Ticker ISR
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 142,112,992
- Market Cap $98.1M
- Description
- Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...